Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.

doi:10.5414/NP301547

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.

Clinical neuropathology - 1 Jan 2000

Pohl Sandra, Dimitrova Lora, Grassow-Narlik Maja, Jöhrens Korinna, Acker Till, Dohmen Hildegard, Herms Jochen, Dorostkar Mario, Hartmann Christian, Hasselblatt Martin, Neumann Manuela, Reifenberger Guido, Felsberg Jörg, Schüller Ulrich, Zoubaa Saida, Lorenz Julia, Rothhammer-Hampl Tanja, Mauch-Mücke Katrin, Riemenschneider Markus J

Abstract excerpt

We previously reported on the first neuropathological round robin trials operated together with Quality in Pathology (QuIP) GmbH in 2018 and 2019 in Germany, i.e., the trials on IDH mutational testing and MGMT promoter methylation analysis [1]. For 2020 and 2021, the spectrum of round robin trials has been expanded to cover the most commonly used assays in neuropathological institutions. In addition to IDH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Deletion

Share to Germany

Share to Histones

Share to Oligodendroglioma

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins B-raf

Share to Telomerase

Source

Open in PubMed

Identifiers

PMID: 36999511
DOI: 10.5414/NP301547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.PMID 36999511Read ↗

Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019.Semantic proximity Read ↗

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.Semantic proximity Read ↗

Real-life implementation of molecular criteria for diagnosing gliomas according to 2021 WHO Classification: a national survey from the Italian Association of Neuro-Oncology and Society of Neurosurgery.Semantic proximity Read ↗

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencingSemantic proximity Read ↗

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas.Semantic proximity Read ↗

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT- NOW Update 3 signature: real-word single center experienceSemantic proximity Read ↗

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.Semantic proximity Read ↗

ROBIN: A unified nanopore-based sequencing assay integrating real-time, intraoperative methylome classification and next-day comprehensive molecular brain tumour profiling for ultra-rapid tumour diagnosticsSemantic proximity Read ↗

Integrating Molecular Analyses with the 2021 WHO Classification for a More Precise Diagnosis of Adult Pilocytic AstrocytomasSemantic proximity Read ↗

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsSemantic proximity Read ↗

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.Semantic proximity Read ↗

Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.